Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Correction: Stent containing CD44-targeting polymeric prodrug nanoparticles that release paclitaxel and gemcitabine in a time interval-controlled manner for synergistic human biliary cancer therapy

Dayeon Yun a, Hyun-Ouk Kim a, Hye Young Son b, Yuna Choi b, Ilkoo Noh c, Jong-Woo Lim a, Jihye Kim a, Haejin Chun a, Geunseon Park a, Dong Ki Lee d, Sung Il Jang d, Eunji Jang b, Yong-Min Huh *b and Seungjoo Haam *a
aDepartment of Chemical and Biomolecular Engineering, Yonsei University, Seoul 120-749, Republic of Korea. E-mail: haam@yonsei.ac.kr
bDepartment of Radiology, Yonsei University, Seoul 120-752, Republic of Korea. E-mail: ymhuh@yuhs.ac
cDepartment of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejon 305-701, Republic of Korea
dDepartment of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, 712 Eonjuro, Gangnam-Gu, Seoul 135-720, Republic of Korea

Received 31st October 2017 , Accepted 31st October 2017

First published on 7th November 2017


Correction for ‘Stent containing CD44-targeting polymeric prodrug nanoparticles that release paclitaxel and gemcitabine in a time interval-controlled manner for synergistic human biliary cancer therapy’ by Dayeon Yun et al., J. Mater. Chem. B, 2017, 5, 6317–6324.


The following text was omitted from the Acknowledgements section of the published article:

This work was also supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (NRF-2015M3A9D7029878 and NRF-2015M3A7B6027963).

 

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


This journal is © The Royal Society of Chemistry 2017